Suppr超能文献

四十年来西班牙肢端肥大症治疗的变化:西班牙肢端肥大症登记处(REA)分析。

Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).

机构信息

Servicio de Endocrinología, Institut Universitari Dexeus, C/Sabino de Arana 5-19, 08028, Barcelona, Spain.

出版信息

Pituitary. 2013 Mar;16(1):115-21. doi: 10.1007/s11102-012-0384-x.

Abstract

Since 1997 there is an online National Registry of acromegalic patients in Spain (REA). We aimed to study changes in acromegaly treatment and outcomes over the last four decades in Spain. In REA clinical and biochemical data are collected at diagnosis and updated every one to 2 years. We analyzed the first treatment received and the different treatments administered according to decade of diagnosis of acromegaly: prior to 1980, 1980-1989, 1990-1999 and 2000-2009. Surgical cure rates according to pretreatment with long-acting somatostatin receptor ligands (SRLs) were also analyzed. 1,658 patients were included of which 698 had accurate follow-up data. Treatment of acromegaly changed over time. Surgery was the main treatment option (83.8 %) and medical treatment was widely used (74.7 %) both maintained over decades, while radiation therapy declined (62.8, 61.6, 42.2 and 11.9 % over decades, p < 0.001). First treatment type also changed: surgery was the first line option up until the last decade in which medical treatment was preferred (p < 0.001). Radiotherapy was barely used as first treatment. Treatment combinations changed over time (p < 0.001). The most common treatment combination (surgery plus medical therapy), was received by 24.4, 16.4, 25.3 and 56.5 % of patients over decades. Medical treatment alone was performed in 7.3, 6, 7.2 and 14.7 % over decades. Type of medical treatment also changed, SRLs becoming the first medical treatment modality in the last decades, whereas dopamine agonist use declined (p < 0.001). Surgical cure rates improved over decades (21, 21, 36 and 38 %, p = 0.002) and were not influenced by SRL pre-surgical use. Acromegaly treatment has changed in Spain in the last four decades. Surgery has been the main treatment option for decades; however, medical therapy has replaced surgery as first line in the last decade and radiotherapy rates have clearly declined. SRLs are the most used medical treatment.

摘要

自 1997 年以来,西班牙一直有一个在线肢端肥大症患者登记处(REA)。我们旨在研究过去四十年中西班牙肢端肥大症治疗和结局的变化。在 REA 中,临床和生化数据在诊断时收集,并每 1-2 年更新一次。我们根据肢端肥大症的诊断十年分析了接受的第一种治疗方法和不同的治疗方法:1980 年前、1980-1989 年、1990-1999 年和 2000-2009 年。我们还分析了根据术前使用长效生长抑素受体配体(SRL)治疗的手术治愈率。共纳入 1658 例患者,其中 698 例有准确的随访数据。肢端肥大症的治疗方法随着时间的推移而变化。手术是主要的治疗选择(83.8%),药物治疗也得到了广泛应用(74.7%),这两种治疗方法都保持了几十年,而放射治疗则下降(62.8%、61.6%、42.2%和 11.9%,p<0.001)。最初的治疗方法也发生了变化:手术一直是过去十年中的首选一线治疗方法,而在最后十年中,药物治疗则更为常见(p<0.001)。放射治疗几乎不作为最初的治疗方法。治疗组合随时间变化(p<0.001)。最常见的治疗组合(手术加药物治疗),在过去几十年中分别有 24.4%、16.4%、25.3%和 56.5%的患者接受了该治疗。在过去几十年中,分别有 7.3%、6%、7.2%和 14.7%的患者单独接受了药物治疗。药物治疗的类型也发生了变化,SRL 成为过去几十年中的第一种药物治疗方法,而多巴胺激动剂的使用则下降(p<0.001)。手术治愈率在过去几十年中有所提高(21%、21%、36%和 38%,p=0.002),并且不受术前 SRL 使用的影响。在过去的四十年中,西班牙的肢端肥大症治疗方法发生了变化。手术一直是几十年来的主要治疗选择;然而,在过去十年中,药物治疗已取代手术成为一线治疗方法,放射治疗率明显下降。SRL 是最常用的药物治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验